Prostate-specific antigen (PSA), total and free
Tumor Markers · also called tPSA, fPSA, Free PSA ratio
What it measures
PSA is a protein produced by prostate cells. Total PSA is used in prostate cancer screening after informed discussion and in monitoring treated cancer; the free PSA percentage helps decide on biopsy when total PSA is 4–10 ng/mL.
Specimen and preparation
- Specimen: Serum or lithium-heparin plasma
- Tube: Gold top
- Preparation: Avoid ejaculation for 48 hours, vigorous cycling, and sampling soon after digital rectal exam, catheterisation or biopsy.
Reference range
| Group | Range |
|---|---|
| Male 40–49 years (total) | <2.5 ng/mL |
| Male 50–59 years (total) | <3.5 ng/mL |
| Male 60–69 years (total) | <4.5 ng/mL |
| Male 70–79 years (total) | <6.5 ng/mL |
| Free/total ratio (total 4–10) | >25% favours benign |
Reference ranges differ between laboratories, methods and populations. Always use the range printed on your own lab report.
Causes of high values
- Prostate cancer
- Benign prostatic hyperplasia
- Prostatitis and urinary infection
- Urinary retention or instrumentation
Causes of low values
- 5-alpha-reductase inhibitors (finasteride, halves PSA)
- After prostatectomy (should be undetectable)
- Obesity (dilution)
Method
Chemiluminescent immunoassay
Good to know
Free PSA below 10% raises the probability of cancer. A rising PSA after radical treatment indicates biochemical recurrence.
Related tests
📱 Practise with a timer, track your score and earn certificates in the free MLT Globe app – Google Play or practise online.